Top compounds associated with response to BRMS1


Feature Type Standardized
Nominal ANOVA
mRNA purmorphamine CTRPv2 pan-cancer AAC -0.077 0.05
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.074 0.05
mRNA BRD-K80183349 CTRPv2 pan-cancer AAC -0.066 0.05
mRNA BRD-K49290616 CTRPv2 pan-cancer AAC -0.15 0.05
mRNA ceranib-2 CTRPv2 pan-cancer AAC -0.066 0.05
mRNA apicidin CTRPv2 pan-cancer AAC -0.062 0.05
mRNA staurosporine CTRPv2 pan-cancer AAC -0.14 0.05
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.07 0.05
mRNA GSK-1904529A GDSC1000 pan-cancer AAC 0.067 0.06
mRNA Fumonisin B1 CTRPv2 pan-cancer AAC -0.073 0.06
Download CSV